Log on / register
Feedback | Support | My details
Open AccessHighly AccessResearch article

Glucosamine increases hyaluronic acid production in human osteoarthritic synovium explants

EJ Uitterlinden1 email, JLM Koevoet1,2 email, CF Verkoelen^ 3 email, SMA Bierma-Zeinstra4 email, H Jahr1 email, H Weinans1 email, JAN Verhaar1 email and GJVM van Osch1,2 email

1Dept. of Orthopaedics, Erasmus MC, University Medical Centre Rotterdam, the Netherlands

2Dept. of Otorhinolaryngology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands

3Dept. of Urology, Erasmus MC, University Medical Centre Rotterdam, the Netherlands

4Dept. of General Practice, Erasmus MC, University Medical Centre Rotterdam, the Netherlands

author email corresponding author email^Deceased

BMC Musculoskeletal Disorders 2008, 9:120doi:10.1186/1471-2474-9-120

Published: 11 September 2008

Abstract

Background

Glucosamine (GlcN) used by patients with osteoarthritis was demonstrated to reduce pain, but the working mechanism is still not clear. Viscosupplementation with hyaluronic acid (HA) is also described to reduce pain in osteoarthritis. The synthesis of HA requires GlcN as one of its main building blocks. We therefore hypothesized that addition of GlcN might increase HA production by synovium tissue.

Methods

Human osteoarthritic synovium explants were obtained at total knee surgery and pre-cultured for 1 day. The experimental conditions consisted of a 2 days continuation of the culture with addition of N-Acetyl-glucosamine (GlcN-Ac; 5 mM), glucosamine-hydrochloride (GlcN-HCl; 0.5 and 5 mM), glucose (Gluc; 0.5 and 5 mM). Hereafter HA production was measured in culture medium supernatant using an enzyme-linked binding protein assay. Real time RT-PCR was performed for hyaluronic acid synthase (HAS) 1, 2 and 3 on RNA isolated from the explants.

Results

0.5 mM and 5 mM GlcN-HCl significantly increased HA production compared to control (approximately 2 – 4-fold), whereas GlcN-Ac had no significant effect. Addition of 5 mM Gluc also increased HA production (approximately 2-fold), but 0.5 mM Gluc did not. Gene expression of the HA forming enzymes HAS 1, 2 and 3 was not altered by the addition of GlcN or Gluc.

Conclusion

Our data suggest that exogenous GlcN can increase HA production by synovium tissue and is more effective at lower concentrations than Gluc. This might indicate that GlcN exerts its potential analgesic properties through stimulation of synovial HA production.


© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.